Anthony Fauci did not invent AZT or approve it. As head of the federal government’s main AIDS research institute, he oversaw much of the research that decided how the drug was used.1PubMed. On Call: A Doctor’s Journey in Public Service That made him the public face of its hopes and failures, praised by some and accused of mass murder by others.2Los Angeles Times. Commentary: Farewell to Peter Duesberg, a godfather of scientific disinformation The record that holds up is more mixed and less dramatic than either side usually says. His most lasting mark on the AZT era may be on how sick people get experimental drugs at all, not on the drug itself.
Who Made AZT and Where Fauci Fit In
Scientists at the National Cancer Institute, not Fauci’s institute, helped develop and test the first AIDS drugs, including AZT.3National Cancer Institute. The First AIDS Drugs In March 1987 the FDA approved AZT, also called zidovudine, as the first drug to treat AIDS, and the company Burroughs Wellcome began selling it.4Petrie-Flom Center. What Ever Happened to NIH’s “Fair Pricing” Clause?5U.S. Food and Drug Administration. Virtual Exhibits of FDA History
The FDA decides whether a drug can be sold, and a company sets the price. The research institute has no power to approve or ban anything. Fauci’s influence came through which trials got funded, how they were designed, and what doctors were told.
Fauci led the National Institute of Allergy and Infectious Diseases, or NIAID, the federal agency for infectious disease research, from 1984 until he retired in late 2022.6PubMed. On Call: A Doctor’s Journey in Public Service During the AIDS crisis his institute funded and ran the large networks of clinical trials that tested AIDS drugs, AZT among them.
Fauci became the government’s most visible AIDS scientist, advising presidents and speaking to the press. That visibility made him the target of anger over everything the government did slowly.
A study run by his institute enrolled volunteers at university hospitals around the country, so a patient met it through a local doctor, not a federal official. Many trials used dummy pills, and neither volunteers nor doctors knew who got what until the study ended. Entry rules often required a particular blood count or infection history, so many sick people were turned away. In his own recollection, the push for fair access to treatment for people who couldn’t get into trials grew once AZT arrived in 1987.7Miller Center. Anthony S. Fauci Oral History
How Toxic AZT Was in the Early Years
AZT can slow the bone marrow, where blood cells are made, which cuts the supply of red blood cells and platelets.8PubMed Central. Incidence and Risk Factors of Zidovudine-Induced Anemia in Patients With HIV Infection Receiving Zidovudine-Containing Antiretroviral Therapy The most common results were anemia, meaning too few red blood cells, and low counts of infection-fighting white cells.9PubMed Central. Magnitude and associated factors of anemia among AZT based HAART experienced adult HIV patients at University of Gondar Comprehensive Specialized Referral Hospital, Northwest, Ethiopia, 2019: a retrospective cohort study Stomach and gut side effects made the drug hard for some people to keep taking.10PubMed Central. Magnitude and associated factors of anemia among AZT based HAART experienced adult HIV patients at University of Gondar Comprehensive Specialized Referral Hospital, Northwest, Ethiopia, 2019: a retrospective cohort study
In the 1987 trial in people with AIDS or its earlier symptoms, the drug showed a real benefit but also serious side effects.11PubMed. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial About 24% of people taking AZT developed severe anemia, compared with 4% on dummy pills.12PubMed. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial About 21% on AZT needed repeated blood transfusions, versus 4% on dummy pills.13PubMed. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial About 16% had dangerously low infection-fighting white cells, versus 2% on dummy pills.14PubMed. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial The sickest people, with low immune cell counts or existing anemia, were most likely to be harmed.15PubMed. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial Doctors could lower the dose or pause the drug until blood counts recovered, and many patients were able to continue afterward.
These were serious harms, but not usually deaths caused by the drug. The people in the trial already had advanced AIDS, which was almost always fatal then, so doctors were weighing a risky drug against a disease that killed nearly everyone it reached. Critics who call AZT poison point to real side effects but leave out that comparison.
Early AZT was given at roughly 1,200 to 1,500 mg a day, about twice or more the later standard of around 600 mg. Much of the worst toxicity belonged to that early high-dose period.
The Fight Over Giving AZT to People Without Symptoms
People with HIV can feel completely well for years, so the question was whether to give a toxic drug to someone who feels fine. Side effects are felt right away, while the benefit would have to show up years later, which makes it hard to measure and hard for a patient to feel. That trade-off, an immediate cost against an uncertain future gain, divided doctors and patients.
The U.S. result looked encouraging. In a trial of people with HIV but no symptoms, about 19% on AZT had their disease worsen within two years, compared with 34% on dummy pills.16PubMed. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter This helped make early AZT treatment a common recommendation in the U.S. in the early 1990s.
The British-French Concorde trial compared starting AZT right away with waiting until symptoms appeared.17PubMed. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection After three years, 92% of the early group and 94% of the waiting group were alive, a difference that could be chance.18PubMed. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection And 18% in both groups had developed AIDS or died by three years.19PubMed. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection Early treatment did seem to give a short-lived boost that faded.20PubMed. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection A later reanalysis that accounted for people switching treatment still found no clear benefit for starting early.21PubMed. Impact of treatment changes on the interpretation of the Concorde trial
The trials could disagree because the U.S. trial followed people for a shorter period, catching the early boost Concorde also saw. Concorde ran longer and counted deaths and AIDS. A single drug loses power as HIV adapts to it, so early gains wear off.
Fauci’s institute’s trial networks backed early treatment, so critics hold this against him. Advice based on a real but short-term result later proved too optimistic. It was a scientific misjudgment that many experts shared, not evidence of hiding harm.
Activists, Protests and the Parallel Track
Over a thousand ACT UP demonstrators marched on the NIH campus with a list of demands aimed at Fauci.22WNYC Studios. The Ashes on the Lawn | The Experiment | WNYC Studios They carried a coffin cursing him and burned a giant Fauci head in effigy.23WNYC Studios. The Ashes on the Lawn | The Experiment | WNYC Studios
He was the face of the federal AIDS research effort, so anger at the whole system landed on one person. The demands were about specific policies his institute influenced, including who could join trials and how fast drugs moved. The coffin and burning head were symbolic theater meant to make the dying visible to officials, not a literal accusation of murder.
AZT was the only approved drug, and many people couldn’t tolerate it. Strict entry rules shut out many sick people, and waiting years for results meant dying before any new drug was approved. So activists asked for a “parallel track,” making promising experimental drugs available to patients while formal trials were still underway.24Science. Anthony Fauci View Maelstrom HIV
Fauci proposed a plan to release promising AIDS drugs at the same time formal studies began.25Los Angeles Times. AIDS Patients to Get More Experimental Drugs But when he endorsed it publicly in San Francisco, the FDA was alarmed and he thought he might be fired.26Science. Anthony Fauci View Maelstrom HIV Then President George H. W. Bush liked the idea, and the policy changed.27Science. Anthony Fauci View Maelstrom HIV28Miller Center. Anthony S. Fauci Oral History
Fauci went from target to ally by meeting with activists and taking their arguments seriously. Activists began helping shape how trials were designed. This is the part of his AIDS record even many critics credit.
The Criticism Over Pneumonia Prevention
A type of pneumonia was then the leading killer of people with AIDS.29HuffPost. Whitewashing AIDS History The cheap antibiotic Bactrim was already used to treat it and could also prevent it.30HuffPost. Whitewashing AIDS History
In 1987 activist Michael Callen asked Fauci to issue interim advice urging doctors to give it to high-risk patients.31HuffPost. Whitewashing AIDS History But guidelines did not come until 1989, and nearly 17,000 people with AIDS died of PCP in those two years.32HuffPost. Whitewashing AIDS History
This criticism differs from the AZT claims. It is about an old, cheap drug that was underused, not a new drug that was overused. Officials wanted trial proof first, while activists said the evidence was already strong enough. Not every one of those deaths was preventable, but earlier advice likely would have saved many.
Why AZT Cost So Much
AZT launched at about $8,000 a year, then called the most expensive prescription drug in history.33Petrie-Flom Center. What Ever Happened to NIH’s “Fair Pricing” Clause? The price was the company’s decision, not NIAID’s. Burroughs Wellcome argued that development costs and the risk of a new drug justified it. Critics pointed out that government scientists had helped test the drug, so the public had already contributed. Many patients couldn’t meet the bill, particularly those who had lost jobs or insurance to the illness.
Congress approved $30 million in emergency money for states to cover AZT for low-income patients.34U.S. Food and Drug Administration. Virtual Exhibits of FDA History That funding led to the AIDS Drug Assistance Program of the 1990s.35U.S. Food and Drug Administration. Virtual Exhibits of FDA History After protests and hearings, the company cut the price by 20% in 1989.36Petrie-Flom Center. What Ever Happened to NIH’s “Fair Pricing” Clause? The anger fed into NIH briefly requiring fair pricing for drugs built on its research.
AZT’s Biggest Success Protecting Babies
In February 1994, Fauci’s institute and the child health institute announced that AZT prevented many HIV infections in newborns.37PubMed. Zidovudine for the prevention of HIV transmission from mother to infant About 8% of babies whose mothers got AZT were infected by 18 months, compared with about 26% with dummy pills.38PubMed. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment The risk fell by about two-thirds.39PubMed. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
The regimen had three parts. Women took AZT by mouth during pregnancy, then received it through a vein during labor and delivery. The newborn then took AZT as a syrup for the first six weeks of life. The aim was to lower the amount of virus in the mother and protect the baby at birth and just after.
It became standard care in the U.S. and spread worldwide. Today, with modern treatment, a baby’s infection risk can fall far lower. This is a clear case where a trial run by Fauci’s institute saved lives.
From AZT Alone to Drug Combinations
Because AZT wasn’t fully effective alone, scientists developed more drugs of the same kind, ddI and ddC, the second and third approved.40National Cancer Institute. The First AIDS Drugs AZT, ddI, and ddC all block an enzyme HIV uses to copy its genetic material, so they attack the virus at the same step. Pairing AZT with one of them worked better than AZT alone, but the gain was modest.41National Cancer Institute. The First AIDS Drugs
The real leap came when a drug attacking a different step was added. In the mid-1990s, adding a new class of drugs that blocks a different viral enzyme often pushed the virus to undetectable levels.42National Cancer Institute. The First AIDS Drugs U.S. AIDS deaths, over 40,000 in 1995, fell quickly after this combination therapy arrived.43National Cancer Institute. The First AIDS Drugs
One drug failed where three worked because HIV copies itself fast and makes mistakes that let it escape a single drug. Several drugs at once make escape far less likely.
Modern guidelines now allow some people with well-controlled HIV to use just two drugs, lowering long-term side effects.44PubMed Central. HIV Treatment Paradigm Shifts over the Past 40 Years AZT is rarely used today because newer drugs are safer and easier to take.
Where the Mass Murder Accusation Comes From
Biologist Peter Duesberg, who denied HIV causes AIDS, accused Fauci of mass murder for promoting AZT.45Los Angeles Times. Commentary: Farewell to Peter Duesberg, a godfather of scientific disinformation Fauci called Duesberg’s scientific claims absolute and total nonsense.46gulftoday. Farewell to Duesberg, a godfather of scientific disinformation Critics also argue the first AZT trial was flawed because some patients learned which pills they had and it was stopped early.47Asklepios. Poison by Prescription: The AZT Story
They are right that some patients figured it out, since side effects and blood counts could give it away. That is a real weakness, but it does not by itself explain away the survival difference between the groups. The trial was stopped early because more people on dummy pills were dying, which made continuing it hard to justify. Later trials and years of experience with HIV drugs pointed the same way, so the finding did not depend on that one study.
The early trial’s harms were real, and its benefit was strong enough to stop it early.48PubMed. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial But the murder claim requires that HIV is harmless, yet people were dying of AIDS before AZT existed, and which decades of evidence and the success of HIV drugs contradict. AZT’s toxicity is a fair criticism, while murder is not supported.

